Tirzepatide 20 mg

Tirzepatide is a once-weekly injectable dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist. It is a synthetic 39-amino-acid peptide used with diet and exercise to improve blood sugar control in adults with Type 2 diabetes mellitus and for chronic weight management in adults. It must be used under medical supervision.

Key Features

How does Tirzepatide 20 mg work?

• GIP receptor agonism: Enhances first-phase insulin secretion, improves insulin sensitivity and may reduce food intake through central action.
• GLP-1 receptor agonism: Stimulates glucose-dependent insulin secretion, suppresses glucagon, slows gastric emptying and increases satiety.

Usage 

• Improving glycemic control in adults with Type 2 diabetes mellitus, alongside diet and exercise.
• Chronic weight management in adults with obesity, or with being overweight and a weight-related condition, alongside a reduced-calorie diet and increased physical activity.

Dosage

• Given once weekly by subcutaneous injection, with the dose increased gradually as directed by your prescriber.
• Per the approved prescribing information, treatment typically starts at 2.5 mg weekly for 4 weeks, then increases to 5 mg weekly. Further increases of 2.5 mg are made after at least 4 weeks on the current dose. The maximum is 15 mg weekly.
• The 20 mg total content of this pen or vial supports multiple weekly doses and does not mean a 20 mg dose. Do not self-adjust your dose.

Side effects

• Nausea
• Diarrhea
• Decreased appetite
• Vomiting
• Constipation
• Dyspepsia
• Abdominal pain
• Pancreatitis
• Gallbladder disease
• Acute kidney injury from dehydration
• Severe gastroparesis
• Hypersensitivity
• Hypoglycaemia

Interactions

• Oral medicines: Slowed gastric emptying may change the absorption of oral drugs. Discuss timing with your prescriber, especially for narrow therapeutic index drugs.
• Insulin and sulfonylureas: Increased risk of low blood sugar. Doses may need adjusting.
• Oral contraceptives: May reduce effectiveness.Use a backup method of contraception for 4 weeks after you start treatment and after any increase in dose.
• Warfarin: Monitor as directed by your prescriber.
• Alcohol: May increase the risk of nausea and pancreatitis.

Pharmacokinetics

• Half-life is about 5 days, supports once-weekly dosing.
• Tmax is about 8-72 hours after subcutaneous injection.
• Steady state: about 4 weeks.
• Bioavailability: approx. 80% (subcutaneous).

Precautions

Tell your doctor before use if you have:

• • A history of pancreatitis, gallbladder disease or severe gastrointestinal disease
  • Diabetic retinopathy (rapid glucose lowering may worsen it)
  • Kidney impairment (higher dehydration risk with GI side effects)
  • A history of depression or suicidal thoughts
  • Pregnancy, plans to conceive or breastfeeding

Conclusion

Tirzepatide is a once-weekly dual GIP/GLP-1 receptor agonist for Type 2 diabetes and chronic weight management. It can cause side effects and carries important warnings, so use it only as prescribed and under medical supervision.

FAQs

• What is the use of Tirzepatide 20 mg?
  Tirzepatide 20 mg is used in dealing with Type 2 Diabetes Mellitus and weight management.

• How does Tirzepatide 20 mg may work?
  Tirzepatide 20 mg may work by enhancing first-phase insulin secretion, it also improves insulin sensitivity and acts on GIP receptors in the brain to reduce food intake and increase satiety.

• What can be the possible side effects of Tirzepatide 20 mg?
  The possible side effects can be nausea, diarrhea, decreased appetite, vomiting, constipation, dyspepsia, abdominal pain, pancreatitis and gallbladder disease.

• Is Tirzepatide safe?
  Yes, Tirzepatide is safe when used up-to 15 mg, but you need to consult your healthcare provider prior to taking any such medications or while increasing dosage.

• Is Tirzepatide safe during pregnancy or breastfeeding?
  It is not recommended in pregnancy, and you should tell your doctor if you are planning a pregnancy. Ask your doctor before using it while breastfeeding.

Note:  Tirzepatide is a prescription medicine. This information is for education only and does not replace advice from your healthcare provider.